![Efficacy and Tolerability Outcomes of a Phase II, Randomized, Open-Label, Multicenter Study of a New Water-Dispersible Pediatric Formulation of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in African ... Efficacy and Tolerability Outcomes of a Phase II, Randomized, Open-Label, Multicenter Study of a New Water-Dispersible Pediatric Formulation of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in African ...](https://journals.asm.org/cms/10.1128/aac.00596-17/asset/892b6ee9-6474-4bb1-bea5-4f090daeb698/assets/graphic/zac0011867850001.jpeg)
Efficacy and Tolerability Outcomes of a Phase II, Randomized, Open-Label, Multicenter Study of a New Water-Dispersible Pediatric Formulation of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in African ...
PharmYaring - แจ้งข่าวความเคลื่อนไหวยาใหม่ในบัญชียาโรงพยาบาลยะหริ่ง : Eurartesim (dihydroartemisinin/piperaquine 40mg/320mg tab) for p.f. malaria click http://www.pharmyaring.com/detail.php?c_id=1240 | Facebook
![How data maps are transforming the fight against malaria in Zambia | Global health innovation - global development professionals network | The Guardian How data maps are transforming the fight against malaria in Zambia | Global health innovation - global development professionals network | The Guardian](https://i.guim.co.uk/img/media/ee4579af86af05002e4a75304adae4e6a5c546f3/0_228_6788_4074/master/6788.jpg?width=620&quality=85&auto=format&fit=max&s=24b019b78454ba6a1a53a3d65478834e)